Molecular classifications of gastric cancers: Novel insights and possible future applications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular classifications of gastric cancers: Novel insights and possible future applications
Authors
Keywords
-
Journal
World Journal of Gastrointestinal Oncology
Volume 9, Issue 5, Pages 194
Publisher
Baishideng Publishing Group Inc.
Online
2017-05-12
DOI
10.4251/wjgo.v9.i5.194
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular classification of gastric cancer
- (2016) N.-Y. Chia et al. ANNALS OF ONCOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus
- (2016) Eva-Maria Birkman et al. BMC CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Stromal-Based Signatures for the Classification of Gastric Cancer
- (2016) M. T. Uhlik et al. CANCER RESEARCH
- Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability
- (2016) Xiangchun Li et al. CANCER RESEARCH
- Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses
- (2016) Leandro M. Colli et al. CANCER RESEARCH
- Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer
- (2016) Philip D. Dunne et al. CLINICAL CANCER RESEARCH
- An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients
- (2016) G. Piro et al. CLINICAL CANCER RESEARCH
- Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus–associated gastric carcinoma
- (2016) Min Dong et al. HUMAN PATHOLOGY
- HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research
- (2016) F. Pietrantonio et al. INTERNATIONAL JOURNAL OF CANCER
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
- (2016) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Combined use of PI3K and MEK inhibitors synergistically inhibits lung cancer with EGFR and KRAS mutations
- (2016) ZE-BO JIANG et al. ONCOLOGY REPORTS
- Recent updates of precision therapy for gastric cancer: Towards optimal tailored management
- (2016) Moon Kyung Joo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer
- (2016) Byungho Lim WORLD JOURNAL OF GASTROENTEROLOGY
- HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
- (2016) Valentina Fanotto et al. Oncotarget
- Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
- (2016) Sarah Derks et al. Oncotarget
- Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
- (2016) Chiara Arienti et al. Oncotarget
- Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies
- (2016) Giuseppe Aprile et al. Expert Review of Clinical Pharmacology
- Novel targets in the treatment of advanced gastric cancer: a perspective review
- (2016) Elisa Fontana et al. Therapeutic Advances in Medical Oncology
- Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
- (2015) Nadeera De Silva et al. BRITISH JOURNAL OF CANCER
- Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight
- (2015) Giuseppe Aprile et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma
- (2015) Patrick Tan et al. GASTROENTEROLOGY
- Deregulation of Immune Response Genes in Patients With Epstein-Barr Virus-Associated Gastric Cancer and Outcomes
- (2015) Sun Young Kim et al. GASTROENTEROLOGY
- Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
- (2015) Yung-Jue Bang et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
- (2015) Maybelline Giam et al. Cell Division
- Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
- (2015) G. M. Frampton et al. Cancer Discovery
- Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity
- (2015) Fei Yao et al. Cell Reports
- The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer
- (2015) Ji Yun Lee et al. Scientific Reports
- Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance
- (2015) Qiang Zuo et al. Scientific Reports
- The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey
- (2014) Giuseppe Aprile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
- (2014) Taroh Satoh et al. Gastric Cancer
- Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)
- (2014) Lin Shen et al. Gastric Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment ofHER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
- (2014) Taroh Satoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
- (2014) Timothy Iveson et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
- (2014) Miwako Kakiuchi et al. NATURE GENETICS
- Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis
- (2014) Zhi Peng et al. PLoS One
- Causes and consequences of microsatellite instability in gastric carcinogenesis
- (2014) Sérgia Velho WORLD JOURNAL OF GASTROENTEROLOGY
- Physiological roles of Rho and Rho effectors in mammals
- (2013) Dean Thumkeo et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors
- (2013) Ronggui Guan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil
- (2013) Zhengdeng Lei et al. GASTROENTEROLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
- (2013) Lianhai Zhang et al. Scientific Reports
- Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature
- (2012) Giovanni Corso et al. BMC CANCER
- MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells
- (2012) C.-T. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
- (2012) Dan-dan Wang et al. PLoS One
- Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis
- (2011) M C Camargo et al. BRITISH JOURNAL OF CANCER
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
- (2011) M. G. Manfredi et al. CLINICAL CANCER RESEARCH
- A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours
- (2011) Patrick Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals
- (2011) Özlem Türeci et al. GENE
- IQGAP1 Protein Binds Human Epidermal Growth Factor Receptor 2 (HER2) and Modulates Trastuzumab Resistance
- (2011) Colin D. White et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading
- (2011) Gary J. Doherty et al. MOLECULAR BIOLOGY OF THE CELL
- An Open-Label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors
- (2010) R.-D. Hofheinz et al. CLINICAL CANCER RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion
- (2009) Shuh Narumiya et al. CANCER AND METASTASIS REVIEWS
- Hijacking the Chromatin Remodeling Machinery: Impact of SWI/SNF Perturbations in Cancer
- (2009) B. Weissman et al. CANCER RESEARCH
- Evidence of tumor microsatellite instability in gastric cancer with familial aggregation
- (2009) Corrado Pedrazzani et al. Familial Cancer
- IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesis
- (2009) Colin D. White et al. FEBS LETTERS
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location
- (2009) Gwen Murphy et al. GASTROENTEROLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype
- (2008) Mafalda Pinto et al. CANCER GENETICS AND CYTOGENETICS
- Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers
- (2008) Yvette Schwitalle et al. GASTROENTEROLOGY
- EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number
- (2008) M A Kim et al. HISTOPATHOLOGY
- Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer
- (2008) Axel Walch et al. MODERN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started